Faculty profile

Douglas Lee

ResearcherMedicineUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Douglas Lee

Researcher

Medicine

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
9 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 10 research grants (10 CIHR), most recently in 2024.
Supervised 5 trainees who won CIHR awards, most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

521

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Heart Failure Outcomes Research Health Services Research Risk Prediction Hospitalization Laboratory Testing Population Health Prediction Modeling

Latest papers

Author Correction to “Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]”
Canadian Journal of Cardiology · 2026
Author Correction to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology. Volume 41, Issue 10, Pages 1857-1874. DOI:10.1016/j.cjca.2025.07.027]
Canadian Journal of Cardiology · 2026
Impact of COPD on cardiovascular risk factors and outcomes in people with established cardiovascular disease.
Thorax · 2025

All 17 publications

Latest funding

Lipoprotein(a) utilization, ancestry, and adverse cardiovascular and renal outcomes: a population-based cohort study
CIHR · 2026 · Co-investigator
$550,800
Using Routine Lab Tests to Develop and Validate a New Risk Prediction Model for the Primary Prevention of Cardiovascular Disease
CIHR · 2025 · Co-investigator
$286,876
Sodium Glucose Co-transporter-2 Inhibition (SGLT2i) to Prevent Earliest Events of Heart Failure (SOLVE-HF): A Pilot RCT
CIHR · 2025 · Co-investigator
$1,315,801

All 53 grants and awards

17 publications.

Author Correction to “Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]”

Panel: P, Virani S, Zieroth S, Aleksova N, Anderson K, Clarke B, Ducharme A, Ezekowitz JA, Foroutan F, Giannetti N

Canadian Journal of Cardiology20261 citations

DOI: 10.1016/j.cjca.2026.03.026

Author Correction to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology. Volume 41, Issue 10, Pages 1857-1874. DOI:10.1016/j.cjca.2025.07.027]

Virani S, Zieroth S, Aleksova N, Anderson K, Clarke B, Ducharme A, Ezekowitz JA, Foroutan F, Giannetti N, Jain R

Canadian Journal of Cardiology2026

DOI: 10.1016/j.cjca.2025.12.030

Impact of COPD on cardiovascular risk factors and outcomes in people with established cardiovascular disease.

Cho EE, Maclagan LC, Chu A, Croxford R, Sin DD, Udell JA, Lee D, Austin PC, Gershon AS

Thorax2025

DOI: 10.1136/thorax-2023-220991 PMID: 40032508

Evaluating the quality of care for heart failure hospitalizations in inflammatory arthritis - A population-based cohort study.

Kuriya B, Eder L, Koppikar S, Widdifield J, Chu A, Fang J, Jeong I, Lee D, Udell J

American heart journal plus : cardiology research and practice2025

DOI: 10.1016/j.ahjo.2025.100503 PMID: 39995517

Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%)

Virani S, Zieroth S, Aleksova N, Anderson K, Clarke B, Ducharme A, Ezekowitz JA, Foroutan F, Giannetti N, Jain R

Canadian Journal of Cardiology202523 citations

DOI: 10.1016/j.cjca.2025.07.027

Covert Vascular Brain Injury and Cognitive Dysfunction Among Chinese Adults Living in Canada and China

Ke C, Anand SS, Smith EE, Schulze KM, Moody A, Lear S, Poirier P, Dummer T, Desai D, Thayalasuthan V

Neurology20254 citationsSenior author

DOI: 10.1212/wnl.0000000000210246

Corrigendum to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%). Volume 41, Issue 10, October 2025, Pages 1857-74

Virani S, Zieroth S, Aleksova N, Anderson K, Clarke B, Ducharme A, Ezekowitz JA, Foroutan F, Giannetti N, Jain R

Canadian Journal of Cardiology20251 citations

DOI: 10.1016/j.cjca.2025.12.001

Exposure to air pollutants and subclinical carotid atherosclerosis measured by magnetic resonance imaging: A cross-sectional analysis

Azab SM, Doiron D, Schulze KM, Brook JR, Brauer M, Smith EE, Moody AR, Desai D, Friedrich MG, Bangdiwala SI

PLoS ONE20245 citations

DOI: 10.1371/journal.pone.0309912

Team-Based Diabetes Care in Ontario and Hong Kong: a Comparative Review.

Ke C, Mohammad E, Chan JCN, Kong APS, Leung FH, Shah BR, Lee D, Luk AO, Ma RCW, Chow E, Wei X

Current diabetes reports2023

DOI: 10.1007/s11892-023-01508-0 PMID: 37043089

CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction

McDonald M, Virani S, Chan M, Ducharme A, Ezekowitz JA, Giannetti N, Heckman GA, Howlett JG, Koshman SL, Lepage S

Canadian Journal of Cardiology2021340 citations

DOI: 10.1016/j.cjca.2021.01.017

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2024

Subject: Prospective PhD student: Heart Failure Dear Professor Lee, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Author Correction to “Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%) [Canadian Journal of Cardiology, Volume 41, Issue 10, Pages 1857-1874. DOI: 10.1016/j.cjca.2025.07.027]”" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "BREATHe: B-type natriuretic peptides to reduce events and advance treatment in heart failure" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Douglas Lee

Research

Latest papers

Latest funding

Impact of COPD on cardiovascular risk factors and outcomes in people with established cardiovascular disease.

Evaluating the quality of care for heart failure hospitalizations in inflammatory arthritis - A population-based cohort study.

Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%)

Covert Vascular Brain Injury and Cognitive Dysfunction Among Chinese Adults Living in Canada and China

Corrigendum to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%). Volume 41, Issue 10, October 2025, Pages 1857-74

Exposure to air pollutants and subclinical carotid atherosclerosis measured by magnetic resonance imaging: A cross-sectional analysis

Team-Based Diabetes Care in Ontario and Hong Kong: a Comparative Review.

CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction

Frequent collaborators

Nadia Giannetti

Lisa Mielniczuk

Abhinav Sharma

Sabina Keen

Harriette Van Spall

Amelia Yip

Alexandra King

Adam Grzeslo

Koon Teo

Sonia Anand

Robert McKelvie

Scott Lear

Howard Abrams

Lee Green

Calvin Ke

Jean-Claude Tardif

Paul Poirier

Scott Lear

Salim Yusuf

Karen Harkness

Jean-Claude Tardif

George Tomlinson

Jessica Widdifield

Lihi Eder

Jane Maciver

Eric Horlick

Lusine Abrahamyan

William Wong

Trevor Dummer

Xiaolin Wei

Muhammad Mamdani

Alan Moody

Dany Doiron

Sandi Azab

Russell de Souza

Dena Zeraatkar

Michael Noseworthy

Shrikant Bangdiwala

Murray Krahn

Heather Ross